Skip to main content

ArcherDx Immunoverse

ArcherDx has launched Archer Immunoverse, a suite of immune repertoire sequencing assays. The targeted panels analyze RNA using Archer's patented Anchored Multiplex PCR (AMP) chemistry for open-ended amplification from molecular barcoded adaptors and next-generation sequencing to characterize the immune repertoire. After sequencing, the Immune Repertoire pipeline is used to identify clonotypes. The workflow requires less than 3.5 hours of hands-on time and between 25 nanograms and 2 micrograms of input RNA from peripheral blood mononuclear cells, formalin-fixed paraffin-embedded tissue, or fresh frozen tissue.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.